Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant610 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01006980 | A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3) | completed | Phase 3 | 675 | Hoffmann-La RocheINDUSTRY | 12 | Sep 28, 2016 | clinicaltrials |
| NCT01829971 | A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | terminated | Phase 1 | 155 | Mirna Therapeutics, Inc.INDUSTRY | 2 | Sep 27, 2016 | clinicaltrials |
| NCT02581228 |
| Multi-Centre, Retrospective, Open Label Study, to Validate ML-PrediCare by Patients With Melanoma Under 1st and 2nd Lines of Immunotherapy |
| unknown |
| — |
| 500 |
| Optimata Ltd.INDUSTRY |
| 1 |
| Sep 27, 2016 |
| clinicaltrials |
| NCT02862145 | Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions(MRX34-102) | withdrawn | Phase 1 / Phase 2 | 0 | Mirna Therapeutics, Inc.INDUSTRY | 0 | Sep 27, 2016 | clinicaltrials |
| NCT00597272 | Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma | completed | N/A | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT01777776 | Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma. | terminated | Phase 1 / Phase 2 | 28 | Array BioPharmaINDUSTRY | 4 | Sep 13, 2016 | clinicaltrials |
| NCT01092728 | Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma | terminated | Phase 2 | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 5, 2016 | clinicaltrials |
| NCT01935453 | A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer | completed | Phase 1 | 18 | OrienGene Biotechnology Ltd.INDUSTRY | 1 | Sep 1, 2016 | clinicaltrials |
| NCT02884362 | Prospective Melanoma Database | unknown | — | 10,000 | Institut Claudius RegaudOTHER | 1 | Aug 31, 2016 | clinicaltrials |
| NCT02883933 | Clinical and Histological Features of Head and Neck Melanoma(head neck-mel) | completed | — | 1,548 | CHU de ReimsOTHER | 1 | Aug 30, 2016 | clinicaltrials |
| NCT01356771 | Melanoma Risk Assessment & Tailored Intervention(PennSCAPE) | completed | N/A | 323 | University of PennsylvaniaOTHER | 1 | Aug 19, 2016 | clinicaltrials |
| NCT00580320 | Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma | completed | Phase 1 | 17 | Virginia Commonwealth UniversityOTHER | 1 | Aug 18, 2016 | clinicaltrials |
| NCT01278940 | Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma | completed | Phase 1 / Phase 2 | 31 | Oslo University HospitalOTHER | 0 | Aug 15, 2016 | clinicaltrials |
| NCT01993654 | In Vivo Confocal Microscopy Study of Pigmented Conjunctival Lesions | terminated | — | 17 | Massachusetts Eye and Ear InfirmaryOTHER | 1 | Aug 15, 2016 | clinicaltrials |
| NCT01216696 | Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1(CTLA4 NY-ESO-1) | completed | Phase 2 | 25 | National Center for Tumor Diseases, HeidelbergOTHER | 1 | Aug 12, 2016 | clinicaltrials |
| NCT01248936 | A Study of RO5185426 in Patients With Metastatic Melanoma | completed | Phase 2 | 374 | Hoffmann-La RocheINDUSTRY | 1 | Aug 12, 2016 | clinicaltrials |
| NCT01585350 | A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients(MEL58) | completed | Phase 1 | 53 | Craig L Slingluff, JrOTHER | 1 | Aug 12, 2016 | clinicaltrials |
| NCT01846143 | Evaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies(Mel59) | completed | Phase 1 | 15 | Craig L Slingluff, JrOTHER | 1 | Aug 12, 2016 | clinicaltrials |
| NCT01082887 | A Study of Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg) | terminated | Phase 1 / Phase 2 | 18 | Nantes University HospitalOTHER | 1 | Aug 8, 2016 | clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT00162123 | A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies | completed | Phase 2 | 248 | Bristol-Myers SquibbINDUSTRY | 18 | Jul 27, 2016 | clinicaltrials |
| NCT01312506 | Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls | withdrawn | — | 0 | University of PittsburghOTHER | 0 | Jul 27, 2016 | clinicaltrials |
| NCT00724841 | A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma | terminated | Phase 1 / Phase 2 | 1 | Gemin XINDUSTRY | 1 | Jul 22, 2016 | clinicaltrials |
| NCT02838433 | Study of Anti-telomerase T CD4 Immunity in Melanoma(LyTéloMel) | unknown | N/A | 200 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 20, 2016 | clinicaltrials |
| NCT00948480 | Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells(DCVaccineMel) | completed | Phase 2 | 56 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Jul 15, 2016 | clinicaltrials |
| NCT00005610 | Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung | completed | Phase 2 | 28 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00769704 | Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma | completed | Phase 3 | 437 | BioVex LimitedINDUSTRY | 4 | Jul 13, 2016 | clinicaltrials |
| NCT01432860 | A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination | completed | N/A | 1,000 | Northwestern UniversityOTHER | 1 | Jul 12, 2016 | clinicaltrials |
| NCT00351728 | Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone | completed | — | 174 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 7, 2016 | clinicaltrials |
| NCT00017121 | Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung | completed | Phase 1 | 40 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00098553 | Everolimus in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 53 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00049010 | Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma | completed | N/A | 314 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 1, 2016 | clinicaltrials |
| NCT01468818 | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma | terminated | Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | Jun 27, 2016 | clinicaltrials |
| NCT02062359 | T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma | terminated | Phase 2 | 2 | National Cancer Institute (NCI)NIH | 1 | Jun 24, 2016 | clinicaltrials |
| NCT02809001 | The Effects of Autologous Fat Transfer on Preventing Expanded Skin From Expansion Failure | completed | Phase 1 / Phase 2 | 80 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT00596362 | Treatment With Intravitreal Avastin for Large Uveal Melanomas | completed | N/A | 1 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 17, 2016 | clinicaltrials |
| NCT01120275 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma | terminated | Phase 2 | 36 | National Cancer Institute (NCI)NIH | 1 | Jun 14, 2016 | clinicaltrials |
| NCT02105168 | Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment(MSN) | unknown | N/A | 2,200 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 10, 2016 | clinicaltrials |
| NCT01557114 | Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma(Mel-Ipi-Rx) | terminated | Phase 1 | 19 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 9, 2016 | clinicaltrials |
| NCT02794636 | Interferon Toxicities in Melanoma Treatment(ITMT) | completed | — | 436 | Bristol-Myers SquibbINDUSTRY | 0 | Jun 9, 2016 | clinicaltrials |
| NCT01078961 | An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma | completed | Phase 1 | 11 | Massachusetts General HospitalOTHER | 1 | Jun 8, 2016 | clinicaltrials |
| NCT02759536 | In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma | unknown | Phase 1 / Phase 2 | 30 | The Third Xiangya Hospital of Central South UniversityOTHER | 1 | Jun 7, 2016 | clinicaltrials |
| NCT01316692 | Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma | terminated | Phase 2 | 12 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 30, 2016 | clinicaltrials |
| NCT02352623 | Quality of Life and Surgical Late Effects of Melanoma Treatment | completed | — | 435 | Herlev HospitalOTHER | 1 | May 26, 2016 | clinicaltrials |
| NCT01435499 | Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma | completed | Phase 1 | 21 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 24, 2016 | clinicaltrials |
| NCT01034696 | Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting | completed | — | 250 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 23, 2016 | clinicaltrials |
| NCT00991991 | Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma | terminated | — | 5 | Case Comprehensive Cancer CenterOTHER | 1 | May 17, 2016 | clinicaltrials |
| NCT02061007 | Biomarker Correlates of Hypoxia in Metastatic Melanoma | withdrawn | Phase 2 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | May 9, 2016 | clinicaltrials |
| NCT02285413 | Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients | completed | Phase 2 | 54 | Radboud University Medical CenterOTHER | 1 | May 4, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Sep 28, 2016source: clinicaltrials